Omanghana
New research published in May 2026 suggests that Vitamin D supplementation may help reduce blood pressure—but primarily among specific high-risk groups rather than the general population.
According to recent findings, the benefits of Vitamin D are most pronounced in older adults, individuals with obesity (defined as a BMI over 30), and people with pre-existing Vitamin D deficiency. For these groups, supplementation appears to offer modest but measurable improvements in cardiovascular health.
A 2026 study found that one year of Vitamin D supplementation led to an average reduction of 3.5 mm Hg in systolic blood pressure and 2.8 mm Hg in diastolic blood pressure among older, overweight participants. While these reductions are considered moderate, they are still clinically meaningful, particularly for individuals at higher risk of hypertension-related complications.
Researchers also noted that higher doses of Vitamin D do not necessarily translate into greater benefits. Daily intake levels of around 600–800 IU were found to be just as effective as significantly higher doses, such as 3,750 IU, for blood pressure management. This finding reinforces current guidance from organizations like the Centers for Disease Control and Prevention, which recommends moderate supplementation based on individual needs.
However, for healthy individuals with sufficient Vitamin D levels, the research found little to no significant impact on blood pressure, suggesting that supplementation may not be necessary for the general population.
Scientists believe Vitamin D may influence blood pressure through several biological mechanisms. These include suppressing the renin-angiotensin-aldosterone system (RAAS), which regulates blood volume and vascular resistance, improving the function of blood vessel linings to support better dilation, and affecting calcium levels in vascular smooth muscle cells.
Despite these promising findings, experts caution that the overall evidence remains mixed. While observational studies consistently show an inverse relationship between Vitamin D levels and hypertension, clinical trials have produced varying results. Some researchers point out that many successful trials combined Vitamin D with calcium citrate, making it difficult to determine the independent effect of Vitamin D alone.
As a result, health professionals recommend a targeted approach to supplementation, focusing on individuals most likely to benefit rather than broad, population-wide use.
Source: Omanghana
